000916872 001__ 916872
000916872 005__ 20231027114351.0
000916872 0247_ $$2doi$$a10.1002/mds.29266
000916872 0247_ $$2ISSN$$a0885-3185
000916872 0247_ $$2ISSN$$a1531-8257
000916872 0247_ $$2Handle$$a2128/33842
000916872 0247_ $$2pmid$$a36345092
000916872 0247_ $$2WOS$$aWOS:000879614200001
000916872 037__ $$aFZJ-2023-00164
000916872 082__ $$a610
000916872 1001_ $$0P:(DE-Juel1)178642$$aHoenig, Merle C.$$b0$$eCorresponding author
000916872 245__ $$aThe Concept of Motor Reserve in Parkinson's Disease: New Wine in Old Bottles?
000916872 260__ $$aNew York, NY$$bWiley$$c2023
000916872 3367_ $$2DRIVER$$aarticle
000916872 3367_ $$2DataCite$$aOutput Types/Journal article
000916872 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675167770_18375
000916872 3367_ $$2BibTeX$$aARTICLE
000916872 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000916872 3367_ $$00$$2EndNote$$aJournal Article
000916872 520__ $$aAcross neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease (AD), a disparity between the clinical expression and the extent of pathophysiological burden has been observed. This has fueled the establishment of resilience concepts such as cognitive reserve (CR) and brain reserve (BR) at the beginning of this millennium.1 Since the introduction of these concepts, a plethora of studies have aimed at identifying mechanisms predominantly associated with the mitigation of cognitive decline despite neurodegenerative changes associated with multiple sclerosis, dementia, or healthy aging (ie, resilience).2, 3 In comparison, resilience mechanisms in PD have received far less attention even though they seem equally important given the clinical heterogeneity and long prodromal phase. With the emerging concept of motor reserve (MR), new avenues have opened up focusing on potential neuronal processes providing resilience (ie, relative preservation of motor function) in PD, which can potentially be harnessed for interventional therapies. Importantly, this requires a common understanding of the principles of how to assess resilience in observational studies and how to quantify its underlying mechanisms. Given the head start in identifying pitfalls and precisely delineating the concept of resilience in the AD field, the opportunity lies at hand to benefit from this knowledge for investigations of MR in PD.
000916872 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000916872 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000916872 7001_ $$0P:(DE-HGF)0$$aDzialas, Verena$$b1
000916872 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b2
000916872 7001_ $$0P:(DE-Juel1)169110$$avan Eimeren, Thilo$$b3
000916872 773__ $$0PERI:(DE-600)2041249-6$$a10.1002/mds.29266$$gp. mds.29266$$n1$$p16-20$$tMovement disorders$$v38$$x0885-3185$$y2023
000916872 8564_ $$uhttps://juser.fz-juelich.de/record/916872/files/Movement%20Disorders%20-%202022%20-%20Hoenig%20-%20The%20Concept%20of%20Motor%20Reserve%20in%20Parkinson%20s%20Disease%20New%20Wine%20in%20Old%20Bottles.pdf$$yOpenAccess
000916872 8767_ $$d2023-01-17$$eHybrid-OA$$jDEAL
000916872 909CO $$ooai:juser.fz-juelich.de:916872$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC_DEAL$$popen_access$$popenaire$$qOpenAPC
000916872 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)178642$$aForschungszentrum Jülich$$b0$$kFZJ
000916872 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b2$$kFZJ
000916872 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000916872 9141_ $$y2023
000916872 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000916872 915pc $$0PC:(DE-HGF)0120$$2APC$$aDEAL: Wiley 2019
000916872 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-11
000916872 915__ $$0LIC:(DE-HGF)CCBYNC4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial CC BY-NC 4.0
000916872 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2022-11-11$$wger
000916872 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-11
000916872 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000916872 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-24$$wger
000916872 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOVEMENT DISORD : 2022$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000916872 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMOVEMENT DISORD : 2022$$d2023-10-24
000916872 920__ $$lyes
000916872 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000916872 980__ $$ajournal
000916872 980__ $$aVDB
000916872 980__ $$aUNRESTRICTED
000916872 980__ $$aI:(DE-Juel1)INM-2-20090406
000916872 980__ $$aAPC
000916872 9801_ $$aAPC
000916872 9801_ $$aFullTexts